News
Verisante Technology | Distribution Agreement with Frontiere Medicale...
www.investegate.co.uk
"Skin cancer rates continue to rise in the UK and Ireland year over year," said Daniel Krelle, Co-Founder of Frontmed. "Aura's(TM) impressive ...
DGAP-News: VENITI, Inc. Announces First Uses of Veniti Vici
www.globenewswire.com
DGAP-News: VENITI, Inc. / VENITI, Inc. ...
Frontiere Medicale to market Verisante Aura in UK and Ireland
www.nsmedicaldevices.com
— Frontmed co-founder Daniel Krelle said that the Aura's impressive clinical study results show it can quickly and accurately assist in ... › ...
sortiert nach Relevanz / Datum